Publications

2023

1. A Ezzati, KK Petersen K, E Seng-Tamaccio E, P Goadsby P, D Buse D, RB Lipton
   A Data-Driven Approach to Assess Clinical Heterogeneity in Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
   2023 American Headache Society (AHS)
2. RB Lipton, AG De La Garza, C Wang, CA Derby, MJ Katz, MJ Sliwinski, A Ezzati
   The Association of Blood-based biomarkers and Cognitive Change as Measured by Ecologically Sensitive Digital Biomarkers.
   2023 Alzheimer’s Association International Conference (AAIC)
3. KK Petersen, B Nallapu, RB Lipton, A Ezzati
   Impact of sex and ApoE4 on the longitudinal association of plasma ptau-181 and NFL with cognitive decline in non-demented older adults
   2023 Alzheimer’s Association International Conference (AAIC)
4. B Nallapu, KK Petersen, RB Lipton, A Ezzati
   Predicting cognitive decline in short-term as a viable method to improve recruitment in clinical trials of Alzheimer’s Disease
   2023 Alzheimer’s Association International Conference (AAIC)
5. KK Petersen, B Nallapu, E Grober, C Davatzikos, RB Lipton, A Ezzati
   Developing Integer-based Risk Scores for Predicting the Risk of Incident Cognitive Impairment in Cognitively Normal Older Adults
   2023 Alzheimer’s Association International Conference (AAIC)
6. CT Udeh-Momoh, A Ezzati, Mila Kivipelto, et al
   A Multi-National Collaboration to Assess the Feasibility and Sustainability of Implementing Multimodal Brain Health Promotion Strategies in Sub-Saharan Africa (The AFRICA-FINGERS Project)
   2023 Alzheimer’s Association International Conference (AAIC)
7. KK Petersen, B Nallapu, E Grober, RB Lipton, A Ezzati
   Predictive Value of CSF Inflammatory Biomarkers in Alzheimer’s disease
   2023 Alzheimer’s Association International Conference (AAIC)
8. KK Petersen, B Nallapu, E Grober, C Davatzikos, RB Lipton, A Ezzati
   Predicting of β‐amyloid Positivity Using Integer‐based Risk Scores with Blood‐based Biomarkers
   2023 Alzheimer’s Association International Conference (AAIC)
9. A Ezzati, K Petersen, B Nallapu, R Lipton
   Using Predictive Models to Reduce Heterogeneity in Alzheimer’s Disease Clinical Trials
   2023 American Academy of Neurology (AAN)

2022

1. E Grober, RB Lipton, RA Sperling, KV Papp, KA Johnson, DM Rentz, A Ezzati
   Associations of Stages of Objective Memory Impairment with Amyloid PET and Structural MRI: The A4 Study
   2022 American Academy of Neurology (AAN)
2. A Ezzati, KM Fanning, ML Reed, RB Lipton
   Identifying predictors of treatment-response to different OTC medication classes in acute migraine
   2022 American Headache Society (AHS)
3. E Grober, KK Petersen, J Hassenstab, JC Morris, RB Lipton, A Ezzati
   Stages of Objective Memory Impairment (SOMI) predicts incident cognitive impairment: Results from the Knight ADRC
   2022 Alzheimer’s Association International Conference (AAIC)
4. C Wang, CO Nester, K Chang, LA Rabin, A Ezzati, RB Lipton, MJ Katz
   Modality Matters for Health Disparity Groups on the Montreal Cognitive Assessment (MoCA): Findings from the Einstein Aging Study (EAS)
   2022 Alzheimer’s Association International Conference (AAIC)
5. B Nallapu, KK Petersen, RB Lipton, D Harvey, A Ezzati
   Comparison of Plasma-based Biomarkers and Cognitive Assessments in predicting progression of MCI to Dementia
   2022 Alzheimer’s Association International Conference (AAIC)
6. B Nallapu, KK Petersen, RB Lipton, D Harvey, A Ezzati
   Association of Cognition with Alcohol Consumption in Cognitively Unimpaired Older Adults: Results from the A4 study
   2022 Alzheimer’s Association International Conference (AAIC)
7. KK Petersen, E Grober, RB Lipton, B Nallapu, A Ezzati
   Assessing Risk of Incident Cognitive Impairment Using Stages of Objective Memory Impairment (SOMI) and Cerebrospinal Fluid
   2022 Alzheimer’s Association International Conference (AAIC)
8. KK Petersen, RB Lipton, B Nallapu, A Ezzati
   MRI-guided Clustering of Alzheimer’s Disease patients: A post-hoc analysis of Phase 3 Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
   2022 Alzheimer’s Association International Conference (AAIC)
9. A Ezzati, KK Petersen, B Nallapu, C Davatzikos, D Wolk, LA Rabin, C Habeck, CB Hall, RB Lipton
   Targeting the Correct Population for Trials: A Post-hoc Analysis of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s disease.
   2022 Alzheimer’s Association International Conference (AAIC)
10. A Ezzati, R Lipton, K Petersen
    Simple risk scores for the prediction of brain β-amyloid and tau status in older adults with mild cognitive impairment
    2022 American Academy of Neurology (AAN)
11. A Ezzati, K Petersen, B Nallapu, R Lipton
    Using Predictive Models to Reduce Heterogeneity in Alzheimer’s Disease Clinical Trials
    2022 American Academy of Neurology (AAN)

2021

1. S Lam, RB Lipton, DJ Harvey, AR Zammit, A Ezzati
   The association between white matter hyperintensities and cognitive function among individuals with different amyloid, tau, and neurodegeneration biomarker profiles
   2021 AAIC Neuroscience Next
2. A Ezzati, RB Lipton
   Predictors of cerebral tauopathy across the Alzheimer disease spectrum.
   2021 AAIC Neuroscience Next
3. A Ezzati, D Harvey, K Petersen, R Lipton
   Predictors of cerebral tauopathy in individuals with normal cognition and amnestic mild cognitive impairment (aMCI)
   2021 American Academy of Neurology (AAN)
4. S Lam, R Lipton, D Harvey, A Zammit, A Ezzati
   Association Between White Matter Disease and Cognitive Function is Independent of Alzheimer’s Disease Biomarker Profile
   2021 American Academy of Neurology (AAN)
5. A Ezzati, K Fanning, D Buse, J Pavlovic, M Reed, R Lipton
   Use of predictive modeling to determine treatment-response to OTC Medications in Acute Migraine: Results from the American Migraine Prevalence and Prevention Study (AMPP)
   2021 American Academy of Neurology (AAN)
6. M Rubin-Norowitz, R Lipton, K Petersen, A Ezzati
   The Relationship Between Depressive Symptoms and Cognitive Function in Non-Demented Older Adults Across Different Alzheimer’s Disease Biomarker Profiles
   2021 American Academy of Neurology (AAN)
7. A Ezzati, DC Buse, ML Reed, JM Pavlovic, CE Armand, KM Fanning, RB Lipton
   Predicting treatment-response to prescription acute migraine medications
   2021 American Headache Society (AHS)
8. A Ezzati, PM Thompson, C Davatzikos, DJ Harvey, RB Lipton
   Predicting the risk of incident dementia in older adults: The ADNI-Dementia risk score
   2021 Alzheimer’s Association International Conference (AAIC)
9. K Petersen, E Grober, RB Lipton, RA Sperling, RF Buckley, A Ezzati
   Cognition and hippocampal volume in amyloid positive clinically normal adults: Results from the A4 study
   2021 Alzheimer’s Association International Conference (AAIC)

2020 and earlier

1. A Ezzati, A Golzar, SR Afraz
   Topographic map of the motion aftereffect
   2005 European Conference on Visual Perception (ECVP)
2. M Adibi, A Ezzati
   The effect of flashing stimuli on the motion perception of remote moving objects
   2005 European Conference on Visual Perception (ECVP)
3. A Ezzati, A Golzar, SR Afraz
   Topographic map of motion aftereffect after saccade
   2017 European Conference on Visual Perception (ECVP)
4. A Daneshmand, A Ezzati
   Dynamic shift of visual receptive fields in the motion-detection hierarchy
   2008 European Conference on Visual Perception (ECVP)
5. A Ezzati, F Khadjevand, A Zandvakili, AH Abbassian
   Debility in higher level motion detection in Parkinson’s disease: a clue for attentional rigidity?
   2009 European Conference on Visual Perception (ECVP)
6. S Attarian, A Ezzati, S Talehy-Moineddin, M Sanayei
   Retinotopic organization of high-level aftereffects
   2009 European Conference on Visual Perception (ECVP)
7. A Ezzati, MB Mitchel, SD Shirk, DG Mclaren, BA Ally, A Atri
   Neural Correlates of Face-Name Encoding Using Simultaneous Eye-Tracking and ERP
   2012 American Neurological Association Conference (ANA)
8. A Ezzati, M Zimmerman, M Katz, R Lipton
   The Link between Recent Stress and Hippocampal Measures in Healthy Elderly Adults
   2013 American Academy of Neurology (AAN)
9. A Ezzati, M Katz, M Zimmerman, R Lipton
   Hippocampal Correlates of Depressive Symptoms in Nondemented Elderly Adults
   2013 American Academy of Neurology (AAN)
10. A Ezzati, C Derby, M Katz, M Zimmerman, R Lipton, D Cabral, T Rundek
    Transcranial Doppler cerebral blood flow velocity and cognitive function: Results from the Einstein Aging Study
    2013 Alzheimer’s Association International Conference (AAIC)
11. M Katz, C Wang, A Ezzati, M Sliwinski, M Zimmerman, C Derby, R Lipton
    Stress and risk of amnestic mild cognitive impairment: Results from the Einstein Aging Study
    2013 Alzheimer’s Association International Conference (AAIC)
12. C Derby, A Ezzati, T Rundek, MJ Katz, RB Lipton, J Verghese
    Transcranial Doppler Ultrasound (TCD) Cerebral Blood Flow is Associated with Gait Velocity: Einstein Aging Study
    2013 The Gerontological Society of America (GSA)
13. ME Zimmerman, A Brickman, A Ezzati, MJ Katz, RB Lipton
    Stress, Neuroimaging, and Cognitive Aging
    2013 The Gerontological Society of America (GSA)
14. MJ Katz, CA Derby, C Wang, MJ Sliwinski, A Ezzati, ME Zimmerman, RB Lipton
    Influence of Perceived Stress on Incident Amnestic Mild Cognitive Impairment
    2015 Alzheimer’s Association International Conference (AAIC)
15. V Eslami, M Katz, R White, E Sundermann, J Jiang, A Ezzati, R Lipton
    Pain Intensity and Pain Interference in Older Adults: Role of Gender, Obesity and Inflammation
    2015 American Academy of Neurology (AAN)
16. A Ezzati, MJ Katz, ML Lipton, RB Lipton
    Total intracranial volume and current total brain volume are linked to level of pain in older adults.
    American Academy of Neurology (AAN)
17. ME Zimmerman, AM Brickman, A Ezzati, MJ Katz, MJ Sliwinski, RB Lipton
    Stress and white matter hyperintensities in nondemented older adults
    2015 Alzheimer’s Association International Conference (AAIC)
18. A Ezzati, MJ Katz, MJ Sliwinski, AM Brickman, ME Zimmerman, RB Lipton
    Correlates of memory function in older adults: The importance of white matter hyperintensities and hippocampal volume
    2015 Alzheimer’s Association International Conference (AAIC)
19. A Ezzati, A Brickman, M Zimmerman, M Katz, C Derby, M Lipton, RB Lipton
    Relationship of White Matter Hyperintensity and Cortical Volume with Gait Velocity in Older Adults
    2016 American Academy of Neurology (AAN)
20. A Ezzati, C Wang, R Lipton, D Altschul, M Katz, D Dickson, C Derby
    Vascular Pathology Is Associated with Rate of Cognitive Decline Independent of AD Pathology (Einstein Aging Study)
    2016 American Academy of Neurology (AAN)
21. A Ezzati, M Katz, M Lipton, R Lipton
    Hippocampal atrophy in older adults with chronic pain is associated with higher levels of depressive symptoms
    2017 American Academy of Neurology (AAN)
22. A Ezzati, C Wang, A Zammit, M Katz, M Zimmerman, C Derby, R Lipton
    The temporal relationship between pain intensity and interference and incident dementia: a community-based prospective study
    2017 American Academy of Neurology (AAN)
23. S Attarian, M Janakiram, A Ezzati, RA Gucalp
    Dimethyl sulfoxide (DMSO) cryopreserved stem cell infusion-related seizures: A single institution experience.
    2017 American Society of Oncology (ASCO)
24. ME Zimmerman, MJ Katz, A Ezzati, ML Lipton, AM Brickman, RB Lipton
    White Matter Hyperintensities Modify the Relationship between Hippocampal Volume and Verbal Memory in Older Adults without Dementia
    2017 Alzheimer’s Association International Conference (AAIC)
25. A Ezzati, MJ Katz, ME Zimmerman, CA Derby, RB Lipton
    Health-Related Quality Of Life Measures From Sf-36 Health Survey Predict Incident Dementia In Older Adults
    2018 Alzheimer’s Association International Conference (AAIC)
26. A Ezzati, MJ Katz, CA Derby, ME Zimmerman, RB Lipton
    Depressive symptoms predict incident dementia in a community sample of older adults
    2018 Alzheimer’s Association International Conference (AAIC)
27. A Ezzati, A Zammit, D Harvey, C Habeck, N Mesgarani, C Hall, R Lipton
    Predicting Clinical Course in Persons with Mild Cognitive Impairment using structural MRI.
    2019 American Academy of Neurology (AAN)
28. A Ezzati, AR Zammit, J Hyun, RB Lipton
    The signal and the noise in Alzheimer’s disease: can machine learning methods improve our predictions?
    2019 Alzheimer’s Association International Conference (AAIC)
29. 2020 J Hyun, CB Hall, MJ Katz, A Ezzati, RB Lipton
    The association between mentally challenging occupations and incident dementia differs between non-Hispanic whites and African-Americans.
    2019 Alzheimer’s Association International Conference (AAIC)
30. A Ezzati, R Lipton
    Machine Learning Models Can Improve Efficiency of Alzheimer’s Disease Clinical Trials.
    2020 American Academy of Neurology (AAN)
31. A Ezzati, D Harvey, A Golzar, C Habeck, I Qureshi, A Zammit, RB Lipton
    Risk estimation of Amyloid Beta positivity on PET with Cognitive, CSF Biomarkers, volumetric MRI, APOE, and Demographic information.
    2020 American Academy of Neurology (AAN)
32. M Truelove‐Hill, G Erus, R Pomponio, A Ezzati, J Doshi, M Habes, C Davatzikos
    A predictive, modeling‐based screening tool to enrich amyloid beta positivity in a cognitively normal sample
    2020 Alzheimer’s Association International Conference (AAIC)
33. A Ezzati, C Davatzikos, DA Wolk, PS Aisen, RB Lipton
    Is it time to use predictive models to boost power of Alzheimer’s disease clinical trials? A post‐hoc analysis of phase 3 Solanezumab trials
    2020 Alzheimer’s Association International Conference (AAIC)
34. A Ezzati, DJ Harvey, C Davatzikos, M Truelove‐Hill, C Davatzikos, RB Lipton
    Prediction of longitudinal clinical outcomes of MCI population using Alzheimer’s AT [N] biomarker profiling: Can machine learning methods improve our predictions?
    2020 Alzheimer’s Association International Conference (AAIC)